Tirzepatide: A medication used for weight loss, best administered with guidance from a reputable weight loss clinic
Thanks to this feature, it has the potential to be used as a therapeutic agent against various brain diseases while protecting brain health
Amycretin's unique position: It's the only molecule in late-stage development that offers both a competitive subcutaneous formulation AND a potentially game-changing oral formulation
Adverse drug reactions and toxicity of the food and drug administration-approved antisense oligonucleotide drugs
Available from: Liu QK
2022 DOI: 10.1016/j.cmet.2022.07.013 PMID: 35985340 Read on PubMed The Lancet LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial Urva S, Coskun T, Loh MT, et al